2017
Sandweiss, Alexander J, et al. “Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury.”. J Trauma Acute Care Surg, Jan. 2017, https://doi.org/10.1097/TA.0000000000001626.
Brzica, Hrvoje, et al. “Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke.”. J Cent Nerv Syst Dis, vol. 9, Jan. 2017, p. 1179573517693802, https://doi.org/10.1177/1179573517693802.
Zissimopoulos, Julie M, et al. “Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.”. JAMA Neurol, vol. 74, no. 2, Jan. 2017, pp. 225-32, https://doi.org/10.1001/jamaneurol.2016.3783.
Mosconi, Lisa, et al. “Sex Differences in Alzheimer Risk: Brain Imaging of Endocrine Vs Chronologic Aging.”. Neurology, vol. 89, no. 13, Jan. 2017, pp. 1382-90, https://doi.org/10.1212/WNL.0000000000004425.
Yeh, Chung-Yang, et al. “Targeting a Potassium Channel Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.”. J Neurosci, vol. 37, no. 23, Jan. 2017, pp. 5648-5, https://doi.org/10.1523/JNEUROSCI.3811-16.2017.
Varadaraj, Archana, et al. “TGF-β Triggers Rapid Fibrillogenesis via a Novel TβRII-Dependent Fibronectin-Trafficking Mechanism.”. Mol Biol Cell, vol. 28, no. 9, Jan. 2017, pp. 1195-07, https://doi.org/10.1091/mbc.E16-08-0601.
2016
Forte, Brittany L, et al. “Angiotensin-(1-7)/Mas/Receptor/As/an/Antinociceptive/Agent/in/Cancer-Induced/Bone/Pain.”. Pain, vol. 157, no. 12, Dec. 2016, pp. 2709-21, https://doi.org/10.1097/j.pain.0000000000000690.
Karim, Roksana, et al. “Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life.”. J Am Geriatr Soc, vol. 64, no. 12, Dec. 2016, pp. 2448-56, https://doi.org/10.1111/jgs.14658.
Ronaldson, P T, et al. “Highlights From the AM Assoc of Pharmaceutical Scientists International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations”. Clin Pharmacol Ther, vol. 100, no. 5, Nov. 2016, pp. 419-22, https://doi.org/10.1002/cpt.439.
Snyder, Heather M, et al. “Sex Biology Contributions to Vulnerability to Alzheimer’s Disease: A Think Tank Convened by the Women’s Alzheimer’s Research Initiative.”. Alzheimers Dement, vol. 12, no. 11, Nov. 2016, pp. 1186-9, https://doi.org/10.1016/j.jalz.2016.08.004.
Slosky, Lauren M, et al. “The Cystine Glutamate Antiporter System Xc- Drives Breast Tumor Cell Glutamate Release and Cancer-Induced Bone Pain.”. Pain, vol. 157, no. 11, Nov. 2016, pp. 2605-16, https://doi.org/10.1097/j.pain.0000000000000681.
Lee, Yeon Sun, et al. “Various Modifications of the Amphipathic Dynorphin A Pharmacophore for Rat Brain Bradykinin Receptors.”. Chem Biol Drug Des, vol. 88, no. 4, Oct. 2016, pp. 615-9, https://doi.org/10.1111/cbdd.12789.
Zhao, Liqin, et al. “Sex Differences in Metabolic Aging of the Brain: Insights into Female Susceptibility to Alzheimer’s Disease.”. Neurobiol Aging, vol. 42, June 2016, pp. 69-79, https://doi.org/10.1016/j.neurobiolaging.2016.02.011.
Espeland, Mark A, et al. “Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention.”. Diabetes Care, vol. 39, no. 5, May 2016, pp. 764-71, https://doi.org/10.2337/dc15-2230.
Rettberg, Jamaica R, et al. “Identifying Postmenopausal Women at Risk for Cognitive Decline Within a Healthy Cohort Using a Panel of Clinical Metabolic Indicators: Potential for Detecting an At-Alzheimer’s Risk Metabolic Phenotype.”. Neurobiol Aging, vol. 40, Apr. 2016, pp. 155-63, https://doi.org/10.1016/j.neurobiolaging.2016.01.011.
Zhang, Yan, et al. “17-Cyclopropylmethyl-3,14β-Dihydroxy-4,5α-Epoxy-6β-(4’-Pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.”. ACS Chem Neurosci, vol. 7, no. 3, Jan. 2016, pp. 297-04, https://doi.org/10.1021/acschemneuro.5b00245.
Zhang, Liang, et al. “Altered Brain Energetics Induces Mitochondrial Fission Arrest in Alzheimer’s Disease.”. Sci Rep, vol. 6, Jan. 2016, p. 18725, https://doi.org/10.1038/srep18725.
Jenkins, Laura M, et al. “Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII) Betaglycan Modulates Canonical Wnt β-Catenin Signaling.”. J Biol Chem, vol. 291, no. 49, Jan. 2016, pp. 25716-28, https://doi.org/10.1074/jbc.M116.748624.
Cowell, Scott M, and Lee, Yeon Sun. “Biphalin: The Foundation of Bivalent Ligands.”. Curr Med Chem, vol. 23, no. 29, Jan. 2016, pp. 3267-84.
Lee, Yeon Sun, et al. “Cyclic Non-Opioid Dynorphin A Analogues for the Bradykinin Receptors.”. Bioorg Med Chem Lett, vol. 26, no. 22, Jan. 2016, pp. 5513-6, https://doi.org/10.1016/j.bmcl.2016.10.010.
Remesic, Michael, et al. “Cyclic Opioid Peptides.”. Curr Med Chem, vol. 23, no. 13, Jan. 2016, pp. 1288-303.
Hall, Sara M, et al. “Discovery of Stable Non-Opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.”. ACS Chem Neurosci, vol. 7, no. 12, Jan. 2016, pp. 1746-52, https://doi.org/10.1021/acschemneuro.6b00258.
Hall, Sara M, et al. “Dynorphin A Analogs for the Treatment of Chronic Neuropathic Pain.”. Future Med Chem, vol. 8, no. 2, Jan. 2016, pp. 165-77, https://doi.org/10.4155/fmc.15.164.
Deekonda, Srinivas, et al. “Enkephalin Analogues With N-Phenyl-N-(piperidin-2-Ylmethyl)propionamide Derivatives: Synthesis and Biological Evaluations.”. Bioorg Med Chem Lett, vol. 26, no. 1, Jan. 2016, pp. 222-7, https://doi.org/10.1016/j.bmcl.2015.10.081.